Evidence map›Paper›PMID 29432659›Full record

ArticleJournal of diabetes investigation2018

Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.

Qing Zhou, Qian Ge, Yao Ding, Hua Qu, Huili Wei, Rui Wu, Lu Yao, Qianping Wei, Zhengping Feng, Jian Long and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of diabetes investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Qing ZhouDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID http://orcid.org/0000-0003-2316-5505
Qian GeDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yao DingDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hua QuDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huili WeiDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Rui WuDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lu YaoDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qianping WeiDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhengping FengDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jian LongDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huacong DengDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

National Key Clinical Specialties Construction Program of ChinaNational Natural Science Foundation of China 30570744National Natural Science Foundation of China 30771038National Natural Science Foundation of China 81070639National Natural Science Foundation of China 81270911
6 · The paper itself

Abstract

AIMS/

introductionTo detect serum adipsin levels in individuals with different glucose tolerance, and investigate the relationship between adipsisn and the first phase of insulin secretion. MATERIALS AND

methodsA total of 56 patients with newly diagnosed type 2 diabetes mellitus, 36 patients with impaired glucose tolerance (IGT) and 45 individuals with normal glucose tolerance were enrolled. Intravenous glucose tolerance tests were carried out to evaluate pancreatic β-cell function. The serum levels of adipsin, interleukin-1β and high-sensitivity C-reactive protein were assayed.

resultsSerum adipsin levels were significantly lower in the type 2 diabetes mellitus and the IGT patients than those in the normal glucose tolerance group (P < 0.05). The acute insulin response and area under the curve showed a progressive decrease in the normal glucose tolerance and IGT groups, and decreased to the lowest levels in the type 2 diabetes mellitus group (P < 0.05). Adipsin was found to be negatively correlated with waist-to-hip ratio, free fatty acid, fasting plasma glucose, 2-h postprandial plasma glucose, glycated hemoglobin, homeostasis model assessment of insulin resistance, interleukin-1β and high-sensitivity C-reactive protein (P < 0.05 or P < 0.001), and positively correlated with homeostasis model assessment of β-cell function, high-density lipoprotein cholesterol, the area under the curve of the first phase insulin secretion and acute insulin response (P < 0.05 or P < 0.001). Stepwise multiple regression analysis showed that homeostasis model assessment for β-cell function and acute insulin response were independently related to adipsin (P < 0.05).

conclusionsSerum adipsin levels were lower in type 2 diabetes mellitus and IGT patients, and correlated with the first phase of insulin secretion. Adipsin might be involved in the pathology of type 2 diabetes mellitus.

Indexed as

Insulin SecretionBiomarkersComplement Factor DC-Reactive ProteinDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucoseGlucose IntoleranceGlucose Tolerance TestHumansInsulin-Secreting CellsMaleMiddle AgedPrognosisBiomarkersCFD protein, humanComplement Factor DC-Reactive ProteinGlucoseAdipsinFirst phase of insulin secretionType 2 diabetes mellitus

Identifiers

PMID29432659
PMCPMC6123022
OpenAlexW2792304088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.